BlackRock Advisors’s Applied DNA Sciences Inc Warrant APDNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$13K Sell
26,824
-662
-2% -$527 ﹤0.01% 3540
2016
Q3
$31K Sell
27,486
-5,039
-15% -$5.4K ﹤0.01% 3362
2016
Q2
$37K Sell
32,525
-3,693
-10% -$4.6K ﹤0.01% 3304
2016
Q1
$66K Sell
36,218
-553
-2% -$771 ﹤0.01% 3091
2015
Q4
$62K Buy
36,771
+21,155
+135% +$53.7K ﹤0.01% 3121
2015
Q3
$47K Buy
15,616
+9,116
+140% +$15.1K ﹤0.01% 3330
2015
Q2
$9K Buy
+6,500
New +$7.4K ﹤0.01% 3628

Other funds holding APDNW

BlackRock Advisors's APDNW Position: Q4 2016 in Review

BlackRock Advisors reduced its Applied DNA Sciences Inc Warrant (APDNW) stake by 2.4% in Q4 2016, selling an estimated $527 and leaving 26,824 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #3540.

BlackRock Advisors first reported a position in APDNW in Q2 2015 and has held it in 7 quarters since. The position peaked at $66K in Q1 2016. 10 funds tracked by Wall St. Rank hold APDNW as of Q4 2016.

  • BlackRock Advisors held 26,824 shares of Applied DNA Sciences Inc Warrant worth $13K as of Q4 2016.
  • BlackRock Advisors sold 662 Applied DNA Sciences Inc Warrant shares in Q4 2016, an estimated $527.
  • Applied DNA Sciences Inc Warrant made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3540 holding.
  • BlackRock Advisors first reported a position in Applied DNA Sciences Inc Warrant in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Advisors's Applied DNA Sciences Inc Warrant position peaked at $66K in Q1 2016.
  • 10 funds tracked by Wall St. Rank held Applied DNA Sciences Inc Warrant as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.